Published online before print October 24, 2002, 10.1148/radiol.2253020053
Long-term Prognostic Value of Dobutamine Stress 99mTc-Sestamibi SPECT: Single-Center Experience with 8-year Follow-up1
Arend F. L. Schinkel, MD,
Abdou Elhendy, MD,
Ron T. van Domburg, PhD,
Jeroen J. Bax, MD,
Roelf Valkema, MD,
Jos R. T. C. Roelandt, MD and
Don Poldermans, MD
1 From the Departments of Cardiology (A.F.L.S., A.E. R.T.v.D., J.R.T.C.R., D.P.) and Nuclear Medicine (R.V.), Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, Thoraxcenter Rm Ba 300, 3015 GD Rotterdam, the Netherlands, and the Department of Cardiology, Leiden University Medical Center, the Netherlands (J.J.B.). Received February 14, 2002; revision requested March 7; revision received May 6; accepted June 25. Address correspondence to D.P. (e-mail: poldermans@hlkd.azr.nl).

View larger version (13K):
[in a new window]
|
Figure 1. Kaplan-Meier survival curves for cardiac death according to results of dobutamine stress 99mTc-sestamibi SPECT. The curves indicate that patients with normal stress images maintained a low event rate up to 8 years after stress testing.
|
|

View larger version (14K):
[in a new window]
|
Figure 2. Kaplan-Meier survival curves for cardiac events (cardiac death, nonfatal MI, or revascularization), according to results of dobutamine stress 99mTc-sestamibi SPECT. The annual cardiac event rate was significantly lower in patients with normal perfusion.
|
|

View larger version (12K):
[in a new window]
|
Figure 3. Bar graph shows incremental prognostic value of dobutamine stress 99mTc-sestamibi SPECT over clinical data. Dobutamine stress 99mTc-sestamibi SPECT provided significant prognostic information in addition to clinical data alone.
|
|

View larger version (29K):
[in a new window]
|
Figure 4. Bar graph shows cumulative cardiac event (cardiac death, nonfatal MI, or revascularization) rates per year according to SSS. An abnormal perfusion pattern, as well as the SSS, provided additional incremental prognostic information.
|
|
Copyright © 2002 by the Radiological Society of North America.